Literature DB >> 3217539

Orbital and conjunctival lymphoma treatment and prognosis.

E M Bessell1, J M Henk, J E Wright, R A Whitelocke.   

Abstract

115 patients with lymphoid tumours presenting in the orbit were seen between 1970 and 1984. The histological types were high-grade malignant lymphoma--18, low-grade malignant lymphoma--43, and indeterminate lymphocytic lesions--54. Eighteen patients were found to have disseminated lymphoma at presentation. The majority of the patients received radiotherapy to the orbit; local control was achieved in all cases and the ocular morbidity from radiotherapy was low with 11 patients developing lens opacities and 5 a dry eye. Survival of patients with stage I low-grade lymphoma and indeterminate lymphocytic lesions was similar to that of a normal population of the same age distribution. The clinic features and dissemination pattern of the low-grade malignant lymphomata and the indeterminate lymphocytic lesions were identical, suggesting that most, if not all, lymphoid masses presenting in the orbit are neoplastic rather than reactive in nature.

Entities:  

Mesh:

Year:  1988        PMID: 3217539     DOI: 10.1016/0167-8140(88)90218-6

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

1.  Electron therapy for orbital and periorbital lesions using customized lead eye shields.

Authors:  Keiji Hayashi; Kunito Hatsuno; Ryo-ichi Yoshimura; Toshiaki Iida; Fumio Ayukawa; Kazuma Toda; Hisashi Taniguchi; Hitoshi Shibuya
Journal:  Ophthalmologica       Date:  2008-11-26       Impact factor: 3.250

2.  Intensity-modulated radiation therapy for orbital lymphoma.

Authors:  Sharad Goyal; Alan Cohler; Jayne Camporeale; Venkat Narra; Ning J Yue
Journal:  Radiat Med       Date:  2009-01-08

Review 3.  Radiotherapy and ophthalmology: time for a friendly re-acquaintance.

Authors:  P N Plowman
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

4.  Co-existing conjunctival non-Hodgkin's lymphoma and pulmonary sarcoidosis.

Authors:  P J Ryan; P Stableforth; D T McLeod
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

5.  Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival.

Authors:  C Jenkins; G E Rose; C Bunce; J E Wright; I A Cree; N Plowman; S Lightman; I Moseley; A Norton
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

6.  Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types.

Authors:  M Cahill; C Barnes; P Moriarty; P Daly; S Kennedy
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

7.  Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

Authors:  Sarah E Coupland; Martin Hellmich; Claudia Auw-Haedrich; William R Lee; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

Review 8.  Extranodal marginal zone lymphoma of the ocular adnexa.

Authors:  Alexandra Stefanovic; Izidore S Lossos
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

9.  Primary orbital non-Hodgkin's lymphoma.

Authors:  Sonal Amit; Neetu Purwar; Asha Agarwal; Shrivastava Kanchan
Journal:  BMJ Case Rep       Date:  2012-10-19

Review 10.  [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].

Authors:  S E Coupland
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.